CD40 Ligand Inhibits Endothelial Cell Migration by Increasing Production of Endothelial Reactive Oxygen Species
- 20 August 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (8) , 981-986
- https://doi.org/10.1161/01.cir.0000027107.54614.1a
Abstract
Background— The CD40/CD40 ligand system is involved in atherogenesis. Activated T lymphocytes and platelets, which express high amounts of CD40 ligand (CD40L) on their surface, contribute significa...Keywords
This publication has 23 references indexed in Scilit:
- Dephosphorylation of endothelial nitric oxide synthase contributes to the anti‐angiogenic effects of endostatinThe FASEB Journal, 2002
- Upregulation of TRAF-3 by shear stress blocks CD40-mediated endothelial activationJournal of Clinical Investigation, 2001
- Cu/Zn superoxide dismutase plays a role in angiogenesisInternational Journal of Cancer, 2001
- Requirement for CD154 in the progression of atherosclerosisNature Medicine, 1999
- T Lymphocytes Induce Endothelial Cell Matrix Metalloproteinase Expression by a CD40L-Dependent MechanismThe American Journal of Pathology, 1999
- Reduction of atherosclerosis in mice by inhibition of CD40 signallingNature, 1998
- Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.Journal of Clinical Investigation, 1998
- Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40–CD40 ligand signaling in atherosclerosisProceedings of the National Academy of Sciences, 1997
- Involvement of the Transcription Factor NF-κB in Tubular Morphogenesis of Human Microvascular Endothelial Cells by Oxidative StressMolecular and Cellular Biology, 1996
- Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-αBiochemical Journal, 1989